Cognition Therapeutics, Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:CGTX) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -9.88 M-5.62 M-5.65 M-3.44 M-5.54 M -20.25 M Cash from investing activities ————— — Cash from financing activities 1.3 M752 K33.92 M605 K-233 K 35.04 M Free cash flow -9.88 M-5.62 M-5.65 M-3.44 M-5.54 M -20.25 M

News

Cognition Therapeutics: Clearer FDA Path, But Potential Dilution Risks Remain

Cognition Therapeutics, Inc. (CGTX) Q4 2025 Earnings Call Transcript

Cognition presents data on dementia drug zervimesine at conference

Cognition Therapeutics shifts focus to DLB psychosis treatment

Cognition Therapeutics holds FDA meeting on Lewy bodies dementia drug

Cognition’s DLB drug shows positive results in phase 2 trial

Cognition Therapeutics completes enrollment in expanded access program

Cognition Therapeutics outlines Phase 3 plans for Alzheimer’s drug

Cognition Therapeutics: A High-Stakes Bet On A Single Drug - Why I Hold (NASDAQ:CGTX)

Cognition Therapeutics completes enrollment in Alzheimer’s drug trial

Has ANI Pharmaceuticals (ANIP) Outpaced Other Medical Stocks This Year?

Cognition Therapeutics (CGTX) Moves to Buy: Rationale Behind the Upgrade